Orserdu (elacestrant) Tablets- HOSMAT HOSPITAL PRIVATE LTD

Home>Product>Orserdu (elacestrant) Tablets

Orserdu (elacestrant) Tablets

Purchase Qty: 1
Unit: Box(es)
Fob Unit Price: US $2300
Production Capacity:50
Payment Terms:PayPal , Others(Bitcoin)

Favorite

HOSMAT HOSPITAL PRIVATE LTD

Business Type:Retailer

Country/Region:India

Ddu Verified

HOT Rank

6/10

Product Information

Indication:Orserdu (elacestrant) is an estrogen receptor antagonist indicated for the treatment of postmenopausal women or adult men, with ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast c
Dosage Form:Tablet
Active Ingredients:elacestrant
Route of Administration:Oral
Shelf Life:2 years
Storage:Sealed
Package:Bottle
Place of Origin:india
Qualification:FDA

Description

Orserdu (elacestrant) is an estrogen receptor antagonist indicated for the treatment of postmenopausal women or adult men, with ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer with disease progression following at least one line of endocrine therapy.